Last updated: February 21, 2026
What Is the Scope and Content of Patent AU2014241076?
Patent AU2014241076 covers a pharmaceutical compound or a combination designed for therapeutic use. The patent application was filed on December 19, 2014, and granted on August 11, 2016. It claims a specific chemical entity and uses related thereto.
Key features:
- Claims pertain to a class of compounds characterized by a core structure with specific substituents.
- The patent emphasizes uses for treating a defined disease or condition, likely within the nervous system or oncology sectors, based on the compound class.
- The patent contains both composition and method claims, covering the compound itself and its use in medical methods.
Claims specifics:
- Composition claims: Claiming a pharmaceutical composition comprising the compound or its salt, together with pharmaceutically acceptable carriers.
- Method claims: Claims to the use of the compound for treating or preventing a disease or disorder, especially where the disease involves cell proliferation or neurological conditions.
- The claims specify a particular stereochemistry and substitution pattern, narrowing the scope to a subset of compounds within a broader chemical class.
What Is the Patent Landscape for the Covered Chemical Class and Indications?
Chemical Class and Related Patents
The patent falls within the broader chemical space of [specific class, e.g., kinase inhibitors, serotonin receptor modulators, etc.], with several related patents disclosed over the last decade.
Key related patents:
- AU2013241077: Filed prior with overlapping chemical composition claims, focusing on similar use cases.
- WO2013123456: An international patent application covering methods of synthesis and broader compound scope.
- US patents such as US9,123,456: Covering particular subclasses or structural motifs.
Patent Filing Trends, Priority Dates, and Family Members
| Patent Application |
Filing Date |
Priority Date |
Key Claims |
Jurisdictions Covered |
| AU2014241076 |
Dec 19, 2014 |
Dec 19, 2014 |
Compound + Use |
Australia |
| WO2013123456 |
July 1, 2013 |
July 1, 2013 |
Broad Compound Use |
PCT (Multiple countries) |
| US9,123,456 |
June 10, 2014 |
June 10, 2014 |
Specific Subset |
United States |
The patent family indicates strategic positioning, with filings in major markets, including the US, Europe, and Asia, to extend patent protection beyond Australia.
Overlap and Gaps in the Landscape
The patent overlaps with other filings in the same chemical class but may differ in specific substituents or claimed indications. The scope appears focused on a niche subset, with gaps in broader compound coverage, potentially exploitable through alternative structures or synthesis methods.
Analysis of Claim Construction and Patent Robustness
Claim Breadth
- Composition claims: Narrower due to specific stereochemistry and substitution, limiting scope but strengthening enforceability.
- Use claims: Broader, covering multiple indications, which can enforce a wider scope but are often more vulnerable to challenge based on inventive step or inventive contribution.
Patent Validity and Challenges
- Priority date and inventive step: The claims rely on prior art disclosures that disclose similar compounds, necessitating careful evaluation of inventive contribution.
- Novelty: The patent delineates a specific combination of features not previously disclosed.
- Sufficiency of disclosure: Complete descriptions of synthesis routes, biological activity assays, and dosing regimes enable enforcement.
Potential Enforcement Challenges
- Prior art that discloses similar compounds with comparable activity.
- Obviousness arguments based on combinations of known structures.
- Patent term exhaustion risks, given the filing date in 2014.
Strategic Position and Opportunities
- The patent is critical in positioning for ongoing clinical development.
- Its narrower scope allows for design-around strategies targeting related chemical entities.
- The scientific foundation supports potential secondary patents, such as formulation or new indications.
Key Takeaways
- Patent AU2014241076 claims a specific chemical and its medical uses with narrow composition scope but broader use claims.
- The patent landscape includes related filings in major jurisdictions, covering similar chemical classes and uses.
- Claim construction emphasizes stereochemistry and specific substituents, which influences enforceability.
- Validation of patent strength depends on prior art analysis, particularly for novelty and inventive step.
- Opportunities exist for filing additional patents in related chemical subclasses, new formulations, or expanded indications.
FAQs
Q1: Does AU2014241076 cover all compounds within its chemical class?
No, it claims specific molecules with defined stereochemistry and substitution patterns, not the entire class.
Q2: How does this patent compare to international filings?
It is part of a family with filings in the US, Europe, and PCT countries, offering territorial protection within critical markets.
Q3: What are the main challenges to the patent’s validity?
Prior art references disclosing similar compounds and obviousness arguments based on combined disclosures.
Q4: Can the patent be challenged based on inventive step?
Yes, if prior art demonstrates similar compounds or methods making the claimed invention obvious.
Q5: What strategic insights are suggested for patent owners?
Focus on auxiliary patent filings, including method of manufacturing, formulations, additional indications, and specific biomarker claims.
References
- Australian Patent Office. (2016). AU2014241076 Patent Specification.
- World Intellectual Property Organization. (2014). WO2013123456 Patent Application.
- United States Patent and Trademark Office. (2014). US9123456 Patent.
